LGL Group (NYSEAMERICAN:LGL) Upgraded by Zacks Research to Hold Rating

Zacks Research upgraded shares of LGL Group (NYSEAMERICAN:LGL) to a hold rating in a report released on Thursday morning,Zacks.com reports.

LGL Group Trading Down 2.1%

NYSEAMERICAN LGL opened at $7.00 on Thursday. The company’s 50-day moving average price is $7.14 and its 200-day moving average price is $6.58. The stock has a market cap of $45.78 million, a PE ratio of 63.64 and a beta of 0.31. LGL Group has a 12 month low of $5.45 and a 12 month high of $9.74.

LGL Group (NYSEAMERICAN:LGL) last issued its earnings results on Monday, March 30th. The industrial products company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.09). LGL Group had a return on equity of 1.62% and a net margin of 16.50%.The business had revenue of $0.80 million for the quarter, compared to the consensus estimate of $9.10 million. As a group, sell-side analysts forecast that LGL Group will post 0.06 earnings per share for the current year.

Institutional Trading of LGL Group

A hedge fund recently bought a new stake in LGL Group stock. Citadel Advisors LLC bought a new stake in shares of LGL Group, Inc. (The) (NYSEAMERICAN:LGL) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 13,515 shares of the industrial products company’s stock, valued at approximately $90,000. Citadel Advisors LLC owned approximately 0.25% of LGL Group at the end of the most recent reporting period. Institutional investors own 30.28% of the company’s stock.

Trending Headlines about LGL Group

Here are the key news stories impacting LGL Group this week:

• Positive Sentiment: Sidoti’s forecasts imply LGL Group should stay in the black over the coming quarters, which can support the stock if investors view the earnings outlook as stable and improving.
• Neutral Sentiment: The new research note provides updated EPS estimates for multiple quarters in 2026 and 2027, giving investors a clearer view of expected performance. LGL Group stock information
• Negative Sentiment: The earnings outlook remains fairly small in absolute terms, which may limit enthusiasm for the stock, especially after LGL recently missed quarterly profit and revenue expectations.

About LGL Group

LGL Group Inc is a United States–based company specializing in the development and commercialization of digital pathology and molecular imaging systems for research and clinical laboratories. The company’s core focus lies in enabling high-resolution visualization and quantitative analysis of tissue samples, helping scientists and pathologists accelerate biomarker discovery and diagnostic workflows. LGL Group’s platform combines advanced optics, automated slide scanning and image analysis software to deliver end-to-end solutions tailored to oncology, immunology and neuroscience research.

The company’s flagship offerings include whole-slide scanners capable of rapid, high-throughput scanning at resolutions suited for detailed morphometric and fluorescence studies.